When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
INZY - Inozyme Pharma GAAP EPS of -$0.35 beats by $0.08
Inozyme Pharma Inc.
2023-08-08 14:22:05 ET
Inozyme Pharma press release ( NASDAQ: INZY ): Q2 GAAP EPS of -$0.35 beats by $0.08 .
Cash, cash equivalents, and short-term investments were $140.2 million as of June 30, 2023.
Based on its current plans, the Company now anticipates its cash, cash equivalents, and short-term investments as of June 30, 2023, together with approximately $64.5 million in proceeds from the July 2023 public offering, will enable the Company to fund its cash flow requirements into Q4 2025.